2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$2.99+$0.07 (+2.40%)
Price as of Jun 23, 2026 4:10 PM EDT- $130.9MMarket Cap
- 5.42%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$2.99+$0.07 (+2.40%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.92 | ||
Change | $0.00 (0.00%) | ||
Open | $2.87 | ||
High | $2.97 | ||
Low | $2.85 | ||
Previous Close | $2.92 | ||
Volume | 91,816 | ||
30-Day Average Volume | 174,301 | ||
1-Week Change | -3.63% | ||
1-Month Change | 0.00% | ||
1-Year Change | 5.04% | ||
3-Year Change | -91.45% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.8M | ||
Total Assets | $32.4M | ||
Market Cap | $130.9M | ||
Enterprise Value | $121.7M | ||
Period: QTR TTM FY | |||
Revenue | -$14,000.00 | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$8.9M | ||
EBITDA | -$8.9M | ||
Net Working Capital | $19.5M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | -8,690 | ||
P/B | 6 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue